DMSO Cell Cryopreservation Medium Market Size is predicted to expand with a 9.11% CAGR during the forecast period for 2024-2031.
Dimethyl Sulfoxide (DMSO) is extensively utilized in cell cryopreservation to safeguard cells from harm caused by ice crystal formation during freezing. It aids in the gradual cooling process, which is essential for preventing cell death by entering cell membranes and minimizing ice formation. Although DMSO is effective, it must be handled cautiously due to its potential toxicity. Additionally, the dose of DMSO needs to be carefully adjusted for different cell types in order to strike a balance between cryoprotection and cellular tolerance.
An increase in cellular therapies and biobanking activities is propelling the demand for cell cryopreservation in the market. The growing field of biobanking requires efficient cell cryopreservation techniques to keep various cell types viable and functional for long periods. Furthermore, the rise in the demand for efficient freezing media from various end-users, together with a slew of new products introduced by prominent market participants, is expected to drive the market's expansion.
Manufacturers face challenges when trying to find a balance between sophisticated features, compliance, and cost-effectiveness, which could impact the market accessibility of these devices. In addition, the market for cell cryopreservation was positively affected by the COVID-19 pandemic. The need to store and preserve cells for potential future use arose from the heightened emphasis on research and development pertaining to vaccinations and treatments. The need for cell cryopreservation services and products surged as a result.
Competitive Landscape
Some Major Key Players In The DMSO Cell Cryopreservation Medium Market:
- Thermo Fisher Scientific
- Biolife Solutions
- Kitazato
- STEMCELL
- Sartorius AG
- AMSBIO
- Shanghai Biyuntian Biotechnology Co., Ltd.
- Beijing Baiolaibo Technology Co., Ltd.
- HiMedia
- Biological Industries
- Other Market Players
Market Segmentation:
The DMSO cell cryopreservation medium market is segmented based on Type and application. Based on Type, the market is segmented into stem cells, CHO cells, T cells, and others. The application segment comprises hospitals, research institutes, and Others.
Based On The Type, The Stem Cell Segment Is Accounted As A Major Contributor To The DMSO Cell Cryopreservation Medium Market.
The stem cell DMSO cell cryopreservation medium market is expected to lead with a major global market share. Stem cell preservation is an important application in the cell cryopreservation business. Stem cells are incredibly important in regenerative medicine because they can both repair and generate new tissue. This makes them a game-changer for treating illnesses like chronic diseases and spinal cord injuries.
The Hospital Segment Is To Witness Growth At A Rapid Rate.
The Hospital is an ideal setting for individuals who need medical attention. Hospitals have a significant community role as well. The existence of a hospital is essential for every community. The truth is that a hospital serves as the hub for wellness and medical care in the community, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North American DMSO Cell Cryopreservation Medium Market Holds A Significant Revenue Share.
The North American DMSO cell cryopreservation medium market is expected to record the maximum market revenue share in the near future. It can be attributed to because of the great concentration of cell cryopreservation facilities and the high incidence of chronic diseases in the area. In addition, Asia Pacific is predicted to grow rapidly in the global DMSO cell cryopreservation medium market because of heightened public understanding of the importance of healthcare, a surge in pharmaceutical and biotechnological R&D efforts, and an increase in government funding for such endeavours.
Recent Developments:
- In June 2023, BioLife Solutions, Inc. has introduced a new controlled-rate freezer (CRF) with a larger capacity, in order to expand its existing CRF product range, which now consists of three different form factors. This tabletop freezer meets the important requirement of customers for increased production capacity of cell treatments.
- In Dec 2019, Sartorius agreed to buy a majority stake in Biological Industries, an Israeli company that develops and makes cell growth media. The owners of the company, Kibbutz Beit Haemek and the private equity fund Fortissimo Capital, sold Sartorius just over half of their shares for about €45 million in cash.
DMSO Cell Cryopreservation Medium Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 9.11% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type and Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Thermo Fisher Scientific, Biolife Solutions, Kitazato, STEMCELL, Sartorius AG, AMSBIO, Shanghai Biyuntian Biotechnology Co., Ltd., Beijing Baiolaibo Technology Co., Ltd., HiMedia, and Biological Industries. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
